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Membrane disruptionThe activity of antimicrobial peptides has been shown to dependon the composition of the target cellmembrane.
The bacterial selectivity of most antimicrobial peptides has been attributed to the presence of abundant acidic
phospholipids and the absence of cholesterol in bacterial membranes. The high amount of cholesterol present
in eukaryotic cell membranes is thought to prevent peptide-induced membrane disruption by increasing the
cohesion and stiffness of the lipid bilayer membrane. While the role of cholesterol on an antimicrobial
peptide-induced membrane disrupting activity has been reported for simple, homogeneous lipid bilayer
systems, it is not well understood for complex, heterogeneous lipid bilayers exhibiting phase separation (or
“lipid rafts”). In this study, we show that cholesterol does not inhibit the disruption of raft-containing 1,2‐
dioleoyl‐sn‐glycero‐3‐phosphocholine:1,2‐dipalmitoyol‐sn‐glycero‐3‐phosphocholine model membranes by
four different cationic antimicrobial peptides, MSI-78, MSI-594, MSI-367 and MSI-843 which permeabilize
membranes. Conversely, the presence of cholesterol effectively inhibits the disruption of non-raft containing
1,2‐dioleoyl‐sn‐glycero‐3‐phosphocholine or 1,2‐dipalmitoyol‐sn‐glycero‐3‐phosphocholine lipid bilayers,
even for antimicrobial peptides that do not show a clear preference between the ordered gel and disordered
liquid-crystalline phases. Our results show that the peptide selectivity is not only dependent on the lipid
phase but also on the presence of phase separation in heterogeneous lipid systems.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Antimicrobial peptides (AMPs) are small, highly cationic, amphi-
pathic peptides known for their cell-selective membrane lytic activities
[1–3]. Most AMPs, like magainins or cecropins, preferentially act on
bacterial cells [4–6], yet others like melittin and gramicidins have
been shown to interact with both bacteria and eukaryotic cells [5,7].
Bacterial selectivity is believed to be linked largely to the ability of anti-
microbial peptides to discriminate between different membrane types
[8,9]. For the majority of these peptides, their cationic nature accounts
for the selective disruption of bacterial membranes, since bacterial
membranes contain signiﬁcantly more acidic phospholipids than
eukaryoticmembranes (~10–70% of the total, dependingon the species)
[10]. Furthermore, the distribution of lipids is non-uniform in eukaryotic
cells, with the acidic lipids largely concentrated in the inner leaﬂet in
eukaryotic membranes [11]. As such, studies considering the inﬂuence
of lipids in themembrane targeting of antimicrobial peptides has largely
focused on the role of negatively charged phospholipids. However, thecholine; DPPC, 1,2-dipalmitoyol-
-oleoylphosphatidylcholine;
peptide; LUV, large unilamellar
-crystalline
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rights reserved.action of these peptides is also dependent on membrane cholesterol
levels, a component primarily found in eukaryotic membranes [12].
In most homogeneous lipid systems, cholesterol is known to
increase membrane cohesion and mechanical stiffness [13,14]. The
presence of membrane-stabilizing cholesterol has been shown to pro-
tect human erythrocytes from attack by magainin 2 [9,15]. Previous
studies have also shown a protective effect of cholesterol on the
membrane disrupting activity of other antimicrobial peptides such
as pardaxin [16–19]. From these studies, it has been inferred that
cholesterol plays an important role in the selective targeting of AMPs
to bacterial membranes over eukaryotic ones [8]. However, both
bacterial and eukaryotic cell membranes are actually complexmixtures
of lipids whose physical properties vary non-linearly with the composi-
tion of the membrane. In particular, liquid ordered–liquid disordered
(Lo–Ld) phase separation in eukaryotic membranes (i.e., the formation
of “raft” domains) has been shown to play essential roles in the organi-
zation and activity of membrane proteins [20]. Few studies have
systematically looked atmembranedisruption byAMPs in such systems.
An exception is two studies by the Almeida group, which systematically
studied the membrane permeabilizing activity of δ-lysin in raft-like
palmitoyl-2-oleoylphosphatidylcholine/cholesterol/sphingomyelin
(POPC/Chol/SM) mixtures [21,22]. These studies showed that mem-
brane permeabilization by δ-lysin occurs exclusively in the Ld phase in
membranes with Ld–Lo phase segregation and that the localization of
δ-lysin to the Ld phase results in greater membrane disruption than
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eralize this important result to a diverse set of AMPs encompassing
several membrane disruptive mechanisms, including AMPs that do
not show a clear preference for either the gel or liquid crystalline
phases. Our results further show that phase separation nulliﬁes the
effect of cholesterol against membrane disruption for all the AMPs
tested. Importantly, we show that the formation of the Lo phase by
cholesterol strongly inhibits membrane disruption even for AMPs
that are active against the similarly ordered gel phase, implying
that the resistance to membrane disruption of the Lo phase by
AMPs is not simply a result of increased acyl chain packing or bilayer
thickness.
2. Materials and methods
2.1. Materials
DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine), DPPC (1,2-
dipalmitoyol-sn-glycero-3-phosphocholine), and cholesterol were
obtained from Avanti Polar Lipids Inc. (Alabaster, AL) and used without
further puriﬁcation or modiﬁcation. Chloroform and methanol were
purchased from Aldrich Chemical (Milwaukee, WI). Carboxyﬂuorescein
(99%) was purchased from ACROS (Pittsburg, PA). All of the peptides
were synthesized and donated by Genaera Corporation (Plymouth
Meeting, PA).
2.2. Preparation of lipid vesicles
Stock solutions of DOPC (20 mg/mL), DPPC (20 mg/mL), and cho-
lesterol (20 mg/mL) in chloroform were used to prepare a set of 16
samples with DOPC/DPPC/cholesterol molar ratios of 1/0/0, 80/0/20,
70/0/30, 60/0/40, 0/1/0, 0/80/20, 0/70/30, 0/60/40, 1/1/0, 40/40/20,
35/35/30, 30/30/40, 33/66/0, 26/53/20, 23/46/30, and 20/40/40. The
concentration of total phospholipid (DOPC/DPPC) was held constant
at an initial mixing concentration of 7 mM. The appropriate volumes
of stock solution for each sample were mixed in a small, round-
bottomed ﬂask and the solvent was removed by evaporation over a
gentle stream of dry nitrogen gas. Residual solvent was removed
under vacuum overnight at room temperature. After the complete
removal of solvents, the dry lipid ﬁlms were hydrated at room temper-
ature in the same small, round-bottomed ﬂask with carboxyﬂuorescein
dye at a concentration of 70 mM in 10 mM pH 7.5 sodium phosphate
buffer without NaCl. The hydrated mixture was then carefully mixed
by hand using a small glass rod and then transferred to a snap-cap cen-
trifuge tube. To conclude the mixing process, samples were routinely
subjected to ﬁve freeze–thaw cycles in which each mixture was frozen
via liquid nitrogen submersion and then heated to 60 °C. The mixture
was then kept at a constant 60 °C (well above the chain melting
temperature of both lipids used) and was passed twenty-one times
through a stainless steel extruder containing two nylon ﬁlters and a
polycarbonate membrane containing 100 nm pores obtained from
Fisher Scientiﬁc (Wayne, Mi) to produce a homogenous mixture of
large unilamellar vesicles (LUVs). Non-encapsulated carboxyﬂuorescein
was removed from the vesicle solution through size exclusion chroma-
tographyusing a PD-10 column (AmershamPharmacia Biotech,Uppsala,
Sweden). LUV solution subsequently contained 10 mM sodium phos-
phate buffer and 100 mM NaCl at pH 7.5. This combination of buffers
ensures that the osmotic strength is matched between the inside and
outside of dye-ﬁlled LUVs, as determined by baseline leakage in the
absence of peptide. Freshly prepared LUVs were used for each
experiment.
2.3. Fluorescence experiments
Fluorescence readings were taken at an excitation wavelength of
493 nm and an emission wavelength of 518 nm. A baseline readingwas taken on the solutions prior to the addition of peptide. Immediately
after addition of the AMP, the ﬂuorescence intensity was recorded for
900 s of interaction. The ﬂuorescence signal given by the addition of
peptide was then normalized by the addition of Triton X detergent,
causing all vesicles present to release any remaining dye to obtain the
total possible ﬂuorescent signal.
3. Results and discussion
We have measured the effect of cholesterol on the membrane
disrupting properties of four different antimicrobial peptides (MSI-78,
MSI-594, MSI-843, and MSI-367) against both raft-containing mem-
branes with liquid-disordered–liquid-ordered (Ld–Lo) phase separation
(DOPC/DPPC/Chol) and non-raft membranes in the liquid crystalline
(Lα) and gel phases (DOPC/Chol and DPPC/Chol). The phase boundaries
of these systemshave been extensivelymapped at the temperature used
in this study, 25 °C, by a number of groups [23–28]. The amino acid
sequences and other properties of the AMPs used are given in Fig. 1.
The antimicrobial peptides chosen are highly potent against a broad-
spectrum of both Gram-positive and Gram-negative bacteria and
encompass a diverse set of membrane permeabilizing mechanisms
and peptide–lipid interactions, [29–35] including MSI-78 (pexiganin),
which was in Phase II clinical trials for the treatment of diabetic foot
ulcers. [36–41]
3.1. Membrane disruption by AMPs can be selective for either the gel or
liquid crystalline phase in the absence of cholesterol
The release of the carboxyﬂuorescein dye from LUVs was measured
as a function of time to test for differences in the extent of membrane
disruption induced byMSI-78,MSI-594,MSI-843, andMSI-367 peptides
in each of the 16different lipid systems used in this study (Figs. 2 and 3).
Carboxyﬂuorescein is self-quenched in intact LUVs at the high concen-
tration (40 mM) used in the experiment. Disruption of the membrane
by a peptide allows carboxyﬂuorescein to be released from LUVs,
eliminating the self-quenching effect and therefore increasing the
ﬂuorescence.
Since cholesterol exerts a strong ordering effect on the acyl chain
order of the bilayer [42], we began by examining the degree of mem-
brane disruption by each AMP in LUVs that are either in the ordered
gel phase (DPPC LUVs) or the more disordered liquid crystalline Lα
phase (DOPC LUVs) (Fig. 3, ﬁlled and open circles respectively) [23].
Three of the four antimicrobial peptides used in this investigation
clearly favor a speciﬁc lipid phase. Both MSI-78 and MSI-594 have a
marked selectivity for disordered, liquid crystalline (Lα) phase lipids,
as shown by the greater amounts of dye released in DOPC LUVs com-
pared to DPPC LUVs (open compared to ﬁlled circles in Fig. 3A and B).
This observation is supported by previous investigations showing that
MSI-78 induces signiﬁcant changes in bilayer structure that are indic-
ative of toroidal pore formation [30,39,43–45]. We attribute a similar
mechanism to MSI 594 because MSI-594 is a synthetic hybrid of
MSI-78 (residues 1–11) and the bee venom toxin melittin (residues
12–24) and also shows a similar random coil to alpha-helix structural
transition as MSI-78 [46]. Toroidal pore formation requires partial
insertion of the peptide into the bilayer [31–33]. Such peptide insertion
is dependent upon lipid order and packing, as demonstrated by the
antimicrobial peptide protegrin-1 [47]. The greater degree of mem-
brane disruption observed for MSI-78 and MSI-843 in liquid crystalline
samples therefore matches expectations based on the energetics of
peptide insertion, as peptide insertion is energetically more difﬁcult in
gel phase lipids.
Membrane disruption byMSI-843, however, ismore favorable in gel
phase lipids, as indicated by the greater amounts of dye released in
DPPC liposomes compared to DOPC liposomes in the absence of choles-
terol (ﬁlled circles compared to open circles in Fig. 3C). MSI-843 is a
lipopeptide consisting of a single fully saturated chain of octanoic acid
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Fig. 1. Helical wheel projections, amino acid sequences, and physical parameters of (A) MSI-78, (B) MSI-594, (C) MSI-367, and (D) MSI-843. MSI-78 is an analog of Magainin-2, and
MSI-594 is a hybrid of MSI-78 and melittin, a bee venom toxin.
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ornithine [29]. Observing that the MSI-843 lipopeptide prefers the
more hydrophobic, ordered phase is not surprising, as this behavior is
common to other lipidated peptides [48]. MSI-367 does not appear to
have a strong dependence on a speciﬁc phase, yet it has shown highly
potent activity for each single-phase system. (Fig. 3D) This behavior
could be because the peptide prefers to remain at the lipid–water inter-
face [35], which is similar in both phases.
3.2. Cholesterol inhibits membrane disruption by AMPs in non-raft
membranes
Wenext examined the effect of cholesterol onmembrane disruption
by AMPS in non-raft membranes (DOPC/Chol and DPPC/Chol, open and
ﬁlled circles in Fig. 3, respectively). For all the AMPs tested, AMP
inducedmembrane disruption in non-raft LUVs decreases as the choles-
terol content is increased. However, the concentration dependence of
the effect is different for DOPC and DPPC liposomes. For DOPC mem-
branes, the effect is nonlinear with the cholesterol concentration, with
a sharp decrease in membrane disruption occurring when the choles-
terol concentration was increased above 20%. DOPC LUVs incorporating
20% cholesterol are only slightlymore resistant to disruption thanDOPCLUVs without cholesterol (b5% difference for each AMP) (Fig. 3 open
circles). Only as the cholesterol content is increased beyond the 20%
threshold is a sharp reduction in membrane disruption observed for
all the AMPs tested (~45% at 30% cholesterol). This ﬁnding neatly corre-
sponds with the known phase properties of DOPC cholesterol mixtures.
Below a concentration threshold of 20% cholesterol, DOPC/Chol
membranes exist as a mixture of the Lo and liquid crystalline (Lα)
phases [23]. Above the 20% concentration threshold, DOPC/Chol
liposomes exist purely in the Lo phase [23]. The existence of a sharp
reduction in membrane disruption at 20% cholesterol suggests that
while AMPs are excluded from the Lo phase, they are free to attack Lα
domains on the remainder of themembrane [22].Membrane disruption
in DPPC liposomes, on the other hand, is strongly inhibited even by the
incorporation of 20% cholesterol (Fig. 3, ﬁlled circles). This ﬁnding is
also consistent with the known phase properties of DPPC/cholesterol
membranes,which are almost entirely in the Lo phase at 20% cholesterol
at 25 °C [22,42].
Resistance of the Lo phase to membrane disruption is observed
even in the two AMPs (MSI 843 and MSI 367) that do not show a
clear preference for the less tightly packed liquid crystalline Lα
phase over the rigid gel phase (Fig. 3C and D). The properties of the Lo
phase are in most respects intermediate between the liquid crystalline
Fig. 2. Fluorescence time curves for the release of encapsulated carboxyﬂuorescein dye from 100 nm LUVs upon incubation with the indicated antimicrobial peptide. Each sample
was maintained at a peptide/lipid ratio of 1/1000 and a temperature of 25 °C. Dye release is essentially complete after 900 s for all samples.
3022 A.J. McHenry et al. / Biochimica et Biophysica Acta 1818 (2012) 3019–3024and gel phases, including bilayer thickness, acyl chain ordering, viscos-
ity, and elastic modulus [14,49,50]. Based on these ﬁndings, it might be
expected that membrane disruption in Lo phases should also be inter-
mediate between the values found for the liquid crystalline Lα and gel
phases. However, Fig. 3 suggests that this is clearly not the case. Mem-
brane disruption for all the AMPs tested is clearly lower for the Lo
phase than either the gel or liquid crystalline Lα phases. However, not
all properties of the Lo phase are intermediate between the gel and
liquid crystalline phases. Hydration in the interfacial region of the
membrane is signiﬁcantly lower in the Lo phase compared to the gel
phase [51], most likely due to the formation of hydrogen bonds from
the 3-OH group of cholesterol to the Sn2 and phosphate group of lipids
[52]. This result suggests that cholesterol can compete with the peptide
for electrostatic and hydrogen binding to the Sn2 and phosphate groups
of the lipids.3.3. Raft-domain containing LUVs are disrupted by AMPs irrespective of
the presence of cholesterol
In non-raft membranes, cholesterol strongly inhibits membrane
disruption at moderate concentrations for all the AMPs tested. How-
ever, this is not true for raft type mixtures of lipids in which phase
separation is expected. We observed high fractions of dye release
(80–100%) for all AMPs in both DOPC/DPPC (1/1) and DOPC/DPPC
(1/2) systems when cholesterol was incorporated between 20 and
40 mol% (Fig. 3, open and ﬁlled squares), contrastingwith the strongly
attenuated membrane disruption in non-raft LUVs in this concentra-
tion range (Fig. 3, open and ﬁlled circles). Membrane disruption by
AMPs in phase separated lipid systems does not decrease signiﬁcantly
with increasing membrane cholesterol content as it does for single-
phase lipid systems. Instead, only a slight decrease is observed as the
Fig. 3. Fraction of dye released after 900 s frommodel LUVs (DOPC open circles, DPPC ﬁlled circles, DOPC/DPPC (1/1) open squares; DOPC/DPPC (1/2) ﬁlled squares) as a function of
the concentration of cholesterol present in the membrane when incubated with MSI-78, MSI-594, MSI-843, and MSI-367.
Fig. 4. Cartoon showing membrane disruption in liquid crystalline (Lα) (A), gel (B),
liquid disordered (Ld) (C), and raft membranes with liquid disordered–liquid ordered
coexistence (E), but not in membranes in the liquid ordered phase only (D).
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as opposed to 25–90% change). This ﬁnding is consistent with prefer-
ential targeting of AMP to Lα domains in systems with Lo and Lα coex-
istence (Fig. 4). We cannot exclude an additional effect from line
tension at the Lo–Lα interface based on this data, yet we believe that
the relatively minimal hydrophobic mismatch afforded by our lipid
systems would not be supportive of such a model [53,54].
4. Conclusion
We have shown here the importance of lipid heterogeneity and
phase on antimicrobial peptide selectivity. Most importantly, we
show that the addition of cholesterol to membranes that have phase
separation does not greatly inhibit peptide activity to the extent that
it does for homogeneous lipid systems of either ordered or disordered
lipids. We conclude that cholesterol's protective, membrane stabilizing
effect does not occur to an appreciable level in lipid systems containing
raft domains. These results not only provide insight into the processes
by which MSI-78, MSI-594, MSI-843, and MSI-367 interact with lipid
membranes, but they also broaden the understanding of the interac-
tions involved in general antimicrobial peptide targeting. This informa-
tion may also prove useful for the design of heterogeneous model
membranes for the use of various peptide–lipid interactions.
Acknowledgements
This study was partly supported by research funds from NIH
(GM084018 and GM095640 to A.R.).
References
[1] Y. Shai, Mode of action of membrane active antimicrobial peptides, Biopolymers
66 (2002) 236–248.
[2] B. Bechinger, Insights into the mechanisms of action of host defence peptides
from biophysical and structural investigations, J. Pept. Sci. 17 (2011) 306–314.
3024 A.J. McHenry et al. / Biochimica et Biophysica Acta 1818 (2012) 3019–3024[3] J. Pius, M.R. Morrow, V. Booth, H-2 solid-state nuclear magnetic resonance inves-
tigation of whole Escherichia coli interacting with antimicrobial peptide MSI-78,
Biochemistry 51 (2012) 118–125.
[4] H.C. Chen, J.H. Brown, J.L. Morell, C.M. Huang, Synthetic magainin analogs with
improved antimicrobial activity, FEBS Lett. 236 (1988) 462–466.
[5] H. Steiner, D. Hultmark, A. Engstrom, H. Bennich, H.G. Boman, Sequence and spec-
iﬁcity of 2 anti-bacterial proteins involved in insect immunity, Nature 292 (1981)
246–248.
[6] M. Zasloff, Magainins, a class of antimicrobial peptides from Xenopus skin —
isolation, characterization of 2 active forms, and partial cDNA sequence of a
precursor, Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 5449–5453.
[7] T. Katsu, M. Kuroko, T. Morikawa, K. Sanchika, Y. Fujita, H. Yamamura, M. Uda,
Mechanism of membrane damage induced by the amphipathic peptides
gramicidin-S and melittin, Biochim. Biophys. Acta 983 (1989) 135–141.
[8] E. Glukhov, M. Stark, L.L. Burrows, C.M. Deber, Basis for selectivity of cationic
antimicrobial peptides for bacterial versus mammalian membranes, J. Biol. Chem.
280 (2005) 33960–33967.
[9] K. Matsuzaki, K. Sugishita, N. Fujii, K. Miyajima, Molecular-basis for membrane
selectivity of an antimicrobial peptide, magainin-2, Biochemistry 34 (1995)
3423–3429.
[10] R.F. Epand, P.B. Savage, R.M. Epand, Bacterial lipid composition and the antimicrobial
efﬁcacy of cationic steroid compounds (Ceragenins), Biochim. Biophys. Acta 1768
(2007) 2500–2509.
[11] S. Riedl, D. Zweytick, K. Lohner, Membrane-active host defense peptides —
challenges and perspectives for the development of novel anticancer drugs,
Chem. Phys. Lipids 164 (2011) 766–781.
[12] K. Matsuzaki, Why and how are peptide–lipid interactions utilized for
self-defense? Magainins and tachyplesins as archetypes, Biochim. Biophys. Acta
1462 (1999) 1–10.
[13] E.A. Evans, R. Waugh, Mechano-chemistry of closed, vesicular membrane systems,
J. Colloid Interface Sci. 60 (1977) 286–298.
[14] J.Henriksen, A.C. Rowat, E. Brief, Y.W.Hsueh, J.L. Thewalt,M.J. Zuckermann, J.H. Ipsen,
Universal behavior of membranes with sterols, Biophys. J. 90 (2006) 1639–1649.
[15] K. Matsuzaki, O. Murase, N. Fujii, K. Miyajima, Translocation of a channel-forming
antimicrobial peptide, magainin-2, across lipid bilayers by forming a pore,
Biochemistry 34 (1995) 6521–6526.
[16] R.F. Epand, A. Ramamoorthy, R.M. Epand, Membrane lipid composition and the
interaction of pardaxin: the role of cholesterol, Protein Pept. Lett. 3 (2006) 1–5.
[17] A. Ramamoorthy, D.K. Lee, T. Narasimhaswamy, R.P.R. Nanga, Cholesterol reduces
pardaxin's dynamics-a barrel-stave mechanism of membrane disruption investi-
gated by solid-state NMR, Biochim. Biophys. Acta 1798 (2010) 223–227.
[18] K.A.H. Wildman, D.K. Lee, A. Ramamoorthy, Mechanism of lipid bilayer disruption
by the human antimicrobial peptide, LL-37, Biochemistry 42 (2003) 6545–6558.
[19] K.J. Hallock, D.K. Lee, J. Omnaas, H.I. Mosberg, A. Ramamoorthy, Membrane
composition determines pardaxin's mechanism of lipid bilayer disruption,
Biophys. J. 83 (2002) 1004–1013.
[20] K. Simons, E. Ikonen, Functional rafts in cellmembranes, Nature 387 (1997) 569–572.
[21] A. Pokorny, L.E. Yandek, A.I. Elegbede, A. Hinderliter, P.F.F. Almeida, Temperature
and composition dependence of the interaction of δ-lysin with ternary mixtures
of sphingomyelin/cholesterol/POPC, Biophys. J. 91 (2006) 2184–2197.
[22] A. Pokorny, P.F.F. Almeida, Permeabilization of raft-containing lipid vesicles by
δ-lysin: a mechanism for cell sensitivity to cytotoxic peptides, Biochemistry 44
(2005) 9538–9544.
[23] D. Marsh, Liquid-ordered phases induced by cholesterol: a compendium of binary
phase diagrams, Biochim. Biophys. Acta 1798 (2010) 688–699.
[24] J.H. Davis, J.J. Clair, J. Juhasz, Phase equilibria in DOPC/DPPC-d(62)/cholesterol
mixtures, Biophys. J. 96 (2009) 521–539.
[25] S.L. Veatch, S.L. Keller, Separation of liquid phases in giant vesicles of ternary
mixtures of phospholipids and cholesterol, Biophys. J. 85 (2003) 3074–3083.
[26] S.L. Veatch, I.V. Polozov, K. Gawrisch, S.L. Keller, Liquid domains in vesicles inves-
tigated by NMR and ﬂuorescence microscopy, Biophys. J. 86 (2004) 2910–2922.
[27] T.H. Huang, C.W.B. Lee, S.K. Dasgupta, A. Blume, R.G. Grifﬁn, A C-13 and H-2
nuclear-magnetic-resonance study of phosphatidylcholine cholesterol interactions —
characterization of liquid-gel phases, Biochemistry 32 (1993) 13277–13287.
[28] S.L. Veatch, O. Soubias, S.L. Keller, K. Gawrisch, Critical ﬂuctuations in domain-
forming lipid mixtures, Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 17650–17655.
[29] S. Thennarasu, D.K. Lee, A. Tan, U.P. Kari, A. Ramamoorthy, Antimicrobial activity
and membrane selective interactions of a synthetic lipopeptide MSI-843,
Biochim. Biophys. Acta 1711 (2005) 49–58.
[30] K.J. Hallock, D.K. Lee, A. Ramamoorthy, MSI-78, an analogue of the magainin
antimicrobial peptides, disrupts lipid bilayer structure via positive curvature
strain, Biophys. J. 84 (2003) 3052–3060.
[31] A. Ramamoorthy, S. Thennarasu, D.K. Lee, A.M. Tan, L. Maloy, Solid-state NMR
investigation of the membrane-disrupting mechanism of antimicrobial peptidesMSI-78 and MSI-594 derived from magainin 2 and melittin, Biophys. J. 91
(2006) 206–216.
[32] F. Porcelli, B.A. Buck-Koehntop, S. Thennarasu, A. Ramamoorthy, G. Veglia,
Structures of the dimeric and monomeric variants of magainin antimicrobial
peptides (MSI-78 and MSI-594) in micelles and bilayers, determined by NMR
spectroscopy, Biochemistry 45 (2006) 5793–5799.
[33] P.N. Domadia, A. Bhunia, A. Ramamoorthy, S. Bhattacharjya, Structure, interactions,
and antibacterial activities of MSI-594 derived mutant peptide MSI-594F5A in
lipopolysaccharide micelles: role of the helical hairpin conformation in outer-
membrane permeabilization, J. Am. Chem. Soc. 132 (2010) 18417–18428.
[34] R.F. Epand, W.L. Maloy, A. Ramamoorthy, R.M. Epand, Probing the “charge cluster
mechanism” in amphipathic helical cationic antimicrobial peptides, Biochemistry
49 (2010) 4076–4084.
[35] S. Thennarasu, R. Huang, D.K. Lee, P. Yang, L. Maloy, Z. Chen, A. Ramamoorthy,
Limiting an antimicrobial peptide to the lipid–water interface enhances its bacterial
membrane selectivity: a case study of MSI-367, Biochemistry 49 (2010) 10595–
10605.
[36] B.A. Lipsky, K.J. Holroyd, M. Zasloff, Topical versus systemic antimicrobial therapy
for treating mildly infected diabetic foot ulcers: a randomized, controlled,
double-blinded, multicenter trial of pexiganan cream, Clin. Infect. Dis. 47
(2008) 1537–1545.
[37] H.M. Lamb, L.R. Wiseman, Pexiganan acetate, Drugs 56 (1998) 1047–1052.
[38] E.A. Nelson, S. O'Meara, D. Craig, C. Iglesias, S. Golder, J. Dalton, K. Claxton, S.E.M.
Bell-Syer, E. Jude, C. Dowson, R. Gadsby, P. O'Hare, J. Powell, A series of systematic
reviews to inform a decision analysis for sampling and treating infected diabetic
foot ulcers, Health Technol. Assess. 10 (2006) 1–221.
[39] L.M. Gottler, A. Ramamoorthy, Structure, membrane orientation, mechanism, and
function of pexiganan — a highly potent antimicrobial peptide designed from
magainin, Biochim. Biophys. Acta 1788 (2009) 1680–1686.
[40] A. Giacometti, O. Cirioni, W. Kamysz, G. D'Amato, C. Silvestri, A. Licci, P. Nadolski,
A. Riva, J. Lukasiak, G. Scalise, In vitro activity of MSI-78 alone and in combination
with antibiotics against bacteria responsible for bloodstream infections in neutro-
penic patients, Int. J. Antimicrob. Agents 26 (2005) 235–240.
[41] A. Giacometti, R. Ghiselli, O. Cirioni, F. Mocchegiani, G. D'Amato, F. Orlando, V.
Sisti, W. Kamysz, C. Silvestri, P. Naldoski, J. Lukasiak, V. Saba, G. Scalise, Therapeutic
efﬁcacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat
models, J. Antimicrob. Chemother. 54 (2004) 654–660.
[42] M.R. Vist, J.H. Davis, Phase-equilibria of cholesterol dipalmitoylphosphatidylcholine
mixtures — H-2 nuclear magnetic-resonance and differential scanning calorimetry,
Biochemistry 29 (1990) 451–464.
[43] A. Mecke, D.K. Lee, A. Ramamoorthy, B.G. Orr, M.M.B. Holl, Membrane thinning
due to antimicrobial peptide binding: an atomic force microscopy study of
MSI-78 in lipid bilayers, Biophys. J. 89 (2005) 4043–4050.
[44] K. Yamamoto, S. Vivekanandan, A. Ramamoorthy, Fast NMR data acquisition from
bicelles containing a membrane-associated peptide at natural-abundance, J. Phys.
Chem. B 115 (2011) 12448–12455.
[45] P. Yang, A. Ramamoorthy, Z. Chen, Membrane orientation of MSI-78 measured
by sum frequency generation vibrational spectroscopy, Langmuir 27 (2011)
7760–7767.
[46] A. Bhunia, A. Ramamoorthy, S. Bhattacharjya, Helical hairpin structure of a potent
antimicrobial peptideMSI-594 in lipopolysaccharidemicelles byNMR spectroscopy,
Chem. Eur. J. 15 (2009) 2036–2040.
[47] Y. Ishitsuka, D.S. Pham, A.J. Waring, R.I. Lehrer, K.Y.C. Lee, Insertion selectivity
of antimicrobial peptide protegrin-1 into lipid monolayers: effect of head group
electrostatics and tail group packing, Biochim. Biophys. Acta 1758 (2006)
1450–1460.
[48] T.Y. Wang, R. Leventis, J.R. Silvius, Partitioning of lipidated peptide sequences into
liquid-ordered lipid domains in model and biological membranes, Biochemistry
40 (2001) 13031–13040.
[49] D.A. Brown, E. London, Structure and origin of ordered lipid domains in biological
membranes, J. Membr. Biol. 164 (1998) 103–114.
[50] T.P.W. McMullen, R.N.A.H. Lewis, R.N. McElhaney, Cholesterol–phospholipid
interactions, the liquid-ordered phase and lipid rafts in model and biological
membranes, Curr. Opin. Colloid Interface Sci. 8 (2004) 459–468.
[51] G. M'Baye, Y. Mely, G. Duportail, A.S. Klymchenko, Liquid ordered and gel phases
of lipid bilayers: ﬂuorescent probes reveal close ﬂuidity but different hydration,
Biophys. J. 95 (2008) 1217–1225.
[52] M.B. Sankaram, T.E. Thompson, Cholesterol-induced ﬂuid-phase immiscibility in
membranes, Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 8686–8690.
[53] A.R. Honerkamp-Smith, P. Cicuta, M.D. Collins, S.L. Veatch, M. den Nijs, M. Schick,
S.L. Keller, Line tensions, correlation lengths, and critical exponents in lipid
membranes near critical points, Biophys. J. 95 (2008) 236–246.
[54] A.J. Garcia-Saez, S. Chiantia, P. Schwille, Effect of line tension on the lateral
organization of lipid membranes, J. Biol. Chem. (2007) 33537–33544.
